List of Tables
Table 1. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Trends
Table 2. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Drivers & Opportunity
Table 3. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Challenges
Table 4. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Restraints
Table 5. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Type
Table 9. Key Companies Time to Begin Mass Production of Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT)
Table 10. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Region (2019-2024) & (%)
Table 27. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value, (2025-2030) & (US$ Million)
Table 31. Pfizer Inc. Basic Information List
Table 32. Pfizer Inc. Description and Business Overview
Table 33. Pfizer Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Products, Services and Solutions
Table 34. Revenue (US$ Million) in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business of Pfizer Inc. (2019-2024)
Table 35. Pfizer Inc. Recent Developments
Table 36. Alexion Pharmaceuticals Inc. Basic Information List
Table 37. Alexion Pharmaceuticals Inc. Description and Business Overview
Table 38. Alexion Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Products, Services and Solutions
Table 39. Revenue (US$ Million) in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business of Alexion Pharmaceuticals Inc. (2019-2024)
Table 40. Alexion Pharmaceuticals Inc. Recent Developments
Table 41. BioMarin Pharmaceutical Inc. Basic Information List
Table 42. BioMarin Pharmaceutical Inc. Description and Business Overview
Table 43. BioMarin Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Products, Services and Solutions
Table 44. Revenue (US$ Million) in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business of BioMarin Pharmaceutical Inc. (2019-2024)
Table 45. BioMarin Pharmaceutical Inc. Recent Developments
Table 46. Ultragenyx Pharmaceutical Inc. Basic Information List
Table 47. Ultragenyx Pharmaceutical Inc. Description and Business Overview
Table 48. Ultragenyx Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Products, Services and Solutions
Table 49. Revenue (US$ Million) in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business of Ultragenyx Pharmaceutical Inc. (2019-2024)
Table 50. Ultragenyx Pharmaceutical Inc. Recent Developments
Table 51. Janssen Pharmaceuticals Inc. Basic Information List
Table 52. Janssen Pharmaceuticals Inc. Description and Business Overview
Table 53. Janssen Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Products, Services and Solutions
Table 54. Revenue (US$ Million) in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business of Janssen Pharmaceuticals Inc. (2019-2024)
Table 55. Janssen Pharmaceuticals Inc. Recent Developments
Table 56. Sigma-Tau Pharmaceuticals Inc. Basic Information List
Table 57. Sigma-Tau Pharmaceuticals Inc. Description and Business Overview
Table 58. Sigma-Tau Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Products, Services and Solutions
Table 59. Revenue (US$ Million) in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business of Sigma-Tau Pharmaceuticals Inc. (2019-2024)
Table 60. Sigma-Tau Pharmaceuticals Inc. Recent Developments
Table 61. AbbVie Inc. Basic Information List
Table 62. AbbVie Inc. Description and Business Overview
Table 63. AbbVie Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Products, Services and Solutions
Table 64. Revenue (US$ Million) in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business of AbbVie Inc. (2019-2024)
Table 65. AbbVie Inc. Recent Developments
Table 66. Sanofi SA Basic Information List
Table 67. Sanofi SA Description and Business Overview
Table 68. Sanofi SA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Products, Services and Solutions
Table 69. Revenue (US$ Million) in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business of Sanofi SA (2019-2024)
Table 70. Sanofi SA Recent Developments
Table 71. Shire PLC Basic Information List
Table 72. Shire PLC Description and Business Overview
Table 73. Shire PLC Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Products, Services and Solutions
Table 74. Revenue (US$ Million) in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business of Shire PLC (2019-2024)
Table 75. Shire PLC Recent Developments
Table 76. Merck KGaA Basic Information List
Table 77. Merck KGaA Description and Business Overview
Table 78. Merck KGaA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Products, Services and Solutions
Table 79. Revenue (US$ Million) in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business of Merck KGaA (2019-2024)
Table 80. Merck KGaA Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Downstream Customers
Table 84. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Picture
Figure 2. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value (2019-2030) & (US$ Million)
Figure 4. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Report Years Considered
Figure 5. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in 2023
Figure 7. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Oral Picture
Figure 9. Parenteral Picture
Figure 10. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Clinic
Figure 14. Product Picture of Others
Figure 15. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value (%), (2019-2030)
Figure 28. United States Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application (%), 2023 VS 2030
Figure 34. China Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type (%), 2023 VS 2030
Figure 36. China Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application (%), 2023 VS 2030
Figure 46. India Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Type (%), 2023 VS 2030
Figure 48. India Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Sales Value by Application (%), 2023 VS 2030
Figure 49. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Industrial Chain
Figure 50. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
